Am I eligible for this study? If you over the age of 18 with localized prostate cancer that is “unfavorable intermediate risk” based on your physician’s evaluation and risk factors such as PSA, Gleason score, and tumor stage, you may be able to participate. Your healthcare team is the best source for information about your […]
Read MorePatient Study Videos
Read MoreFrequently Asked Questions Below, you can find FAQs about clinical research and this particular clinical trial.
Read MoreAm I eligible for this study? If you over the age of 18 with localized prostate cancer that is “unfavorable intermediate risk” based on your physician’s evaluation and risk factors such as PSA, Gleason score, and tumor stage, you may be able to participate. Your healthcare team is the best source for information about your […]
Read MoreAbout This Study NRG-GU010 is a clinical study for men with unfavorable intermediate risk prostate cancer that provides treatment options based on gene risk score. The prostate tumor tissue from your biopsy will be tested for different genes that all together predict the risk of your cancer spreading.This is called the Decipher risk score. […]
Read MoreClinical Studies FAQ
Read MoreNRG-GU010 FAQ
Read More